Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OM-85 for prevention of acute respiratory tract infections in elderly adults
ChiCTR1800017306Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Guangxi Medical University
- Start
- Sep 2018
- Modality
- Whole Cell Cancer Vaccines → Cancer Vaccines → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of OM-85 in acute respiratory illness (ARI) (2 arms), sponsored by The First Affiliated Hospital of Guangxi Medical University. Primary endpoint: Number of acute respiratory tract infection episodes. Planned start Sep 2018; status: not yet recruiting.
02
Drugs
OM-85
03
Conditions
acute respiratory illness (ARI)
Beyond the preview
Go deeper on ChiCTR1800017306.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800017306.